Cargando…
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes
Ovarian carcinomas (OCs) are poorly immunogenic and immune checkpoint inhibitors (ICIs) have offered a modest benefit. In this study, high CD3(+) T-cells and CD163(+) tumor-associated macrophages (TAMs) densities identify a subgroup of immune infiltrated high-grade serous carcinomas (HGSCs) with bet...
Autores principales: | Ardighieri, Laura, Missale, Francesco, Bugatti, Mattia, Gatta, Luisa Benerini, Pezzali, Irene, Monti, Matilde, Gottardi, Stefano, Zanotti, Laura, Bignotti, Eliana, Ravaggi, Antonella, Tognon, Germana, Odicino, Franco, Calza, Stefano, Missolo-Koussou, Yoann, Ries, Carola Hermine, Helft, Julie, Vermi, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253056/ https://www.ncbi.nlm.nih.gov/pubmed/34220848 http://dx.doi.org/10.3389/fimmu.2021.690201 |
Ejemplares similares
-
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma
por: Ravaggi, Antonella, et al.
Publicado: (2022) -
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients
por: Bignotti, Eliana, et al.
Publicado: (2020) -
L1CAM expression as a predictor of platinum response in high‐risk endometrial carcinoma
por: Romani, Chiara, et al.
Publicado: (2022) -
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients
por: Tassi, Renata A., et al.
Publicado: (2019) -
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
por: Zanotti, Laura, et al.
Publicado: (2017)